When compared with all other pediatric cancers (FPKM = 14.69), LLT1 expression was significantly overexpressed in B-ALL (FPKM = 32.79) subjects, whereas it was decreased in T-ALL (FPKM = 8.3) subjects. This evidence concerns the gene CLEC2D and cancer.